UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 2, 2003
APPLIED DNA SCIENCES , INC.
------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 2 90519 59-2262718
---------------------------- ----------- -----------------
(State or other jurisdiction Commission (IRS Employer
of Incorporation) File Number Identification No.)
9225 Sunset Boulevard Los Angeles, CA 90069
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's Telephone Number, including area code: (310) 246-1720
PROHEALTH MEDICAL TECHNOLOGIES, INC.
211 West Wall Street, Midland, Texas 70701-4556
(Former name or former address, if changed since last report.)
ITEM 8. CHANGE IN FISCAL YEAR.
The Registrant changed its fiscal year end, effective as of January
31, 2003, from December 31 to September 30. This change was made
upon the unanimous consent of the Board of Directors. The
Registrant's next periodic report will be its Quarterly Report on
Form 10-QSB for the three months ended December 31, 2002.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
APPLIED DNA SCIENCES, INCORPORATED
------------------------------
Lawrence C. Lee
President, CEO and Director